Brief: Crinetics Pharmaceuticals Q2 Net Income USD -115.637 Million
07/08/2025 21:05
Aug 07 (Reuters) - Crinetics Pharmaceuticals Q2 basic EPS USD -1.23. Q2 operating income USD -129.112 million Q2 revenue USD 1.031 million vs. IBES estimate USD 129.2 thousand Q2 operating expenses USD 130.143 million
Recent news on Crinetics Pharmaceuticals
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Crinetics Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Crinetics Q2 revenue jumps on PALSONIFY launch, withdraws guidance
Brief: Crinetics Pharmaceuticals Q2 Net Income USD -120.855 Million